
New HIV Therapy Lenacapavir Shows Promise in Uganda Research
A study by Weill Cornell Medicine confirms that lenacapavir shows minimal resistance in Uganda, bolstering its potential as an effective HIV treatment. With only 1.6% of patients harboring resistance mutations, …
New HIV Therapy Lenacapavir Shows Promise in Uganda Research Read More